ES8600933A1 - Procedimiento para preparar una composicion antihelmitica - Google Patents

Procedimiento para preparar una composicion antihelmitica

Info

Publication number
ES8600933A1
ES8600933A1 ES537825A ES537825A ES8600933A1 ES 8600933 A1 ES8600933 A1 ES 8600933A1 ES 537825 A ES537825 A ES 537825A ES 537825 A ES537825 A ES 537825A ES 8600933 A1 ES8600933 A1 ES 8600933A1
Authority
ES
Spain
Prior art keywords
compositions
proportion
salt
solvent
anthelmintic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537825A
Other languages
English (en)
Other versions
ES537825A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of ES8600933A1 publication Critical patent/ES8600933A1/es
Publication of ES537825A0 publication Critical patent/ES537825A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

METODO DE PREPARACION DE COMPOSICIONES ANTIHELMINTICAS. CONSISTE EN LA DISOLUCION DE AL MENOS 5% P/V DE NITROXINILO DE LEVAMISOL EN UN DISOLVENTE CONSTITUIDO POR ISOSORBURO DE DIMETILO Y/O GLICOFUROL Y UNO O MAS CODISOLVENTES EN LOS QUE LA SAL ES SOLO ESCASAMENTE SOLUBLE TALES COMO AGUA BUTIROLACTONA Y ALCOHOLES; DE MODO QUE LA PROPORCION DE DISOLVENTE O MEZCLA DE DISOLVENTES NO ES INFERIOR AL 25% EN VOLUMEN Y LA SAL PUEDE ALCANZAR LA PROPORCION DE 40% P/V. ESTAS COMPOSICIONES TIENEN APLICACIONES PARA EL TRATAMIENTO CONTRA HELMINTOS INTERNOS EN ANIMALES DE SANGRE CALIENTE COMO GANADO VACUNO Y OVINO CERDOS CABRAS CABALLOS Y PERROS.
ES537825A 1983-11-21 1984-11-21 Procedimiento para preparar una composicion antihelmitica Granted ES537825A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838331037A GB8331037D0 (en) 1983-11-21 1983-11-21 Compositions of matter

Publications (2)

Publication Number Publication Date
ES8600933A1 true ES8600933A1 (es) 1985-10-16
ES537825A0 ES537825A0 (es) 1985-10-16

Family

ID=10552109

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537825A Granted ES537825A0 (es) 1983-11-21 1984-11-21 Procedimiento para preparar una composicion antihelmitica

Country Status (15)

Country Link
JP (1) JPS60123419A (es)
AU (1) AU3564984A (es)
BE (1) BE901095A (es)
CA (1) CA1236402A (es)
CH (1) CH662273A5 (es)
DE (1) DE3442402A1 (es)
DK (1) DK548884A (es)
ES (1) ES537825A0 (es)
FR (1) FR2555047B1 (es)
GB (2) GB8331037D0 (es)
HU (1) HU196307B (es)
IT (1) IT1177262B (es)
NL (1) NL8403528A (es)
NZ (1) NZ210247A (es)
ZA (1) ZA849008B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147883A3 (en) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Aqueous non-aggressive anthelmintic pour-on formulations
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
CN100500648C (zh) * 2006-12-29 2009-06-17 浙江工业大学 一种硝碘酚腈的合成方法
BRPI0904365A2 (pt) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais
CN103260620A (zh) * 2010-12-27 2013-08-21 英特维特国际股份有限公司 包含三缩四乙二醇的外用局部异噁唑啉制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
DE3163536D1 (en) * 1980-11-20 1984-06-14 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ202422A (en) * 1981-11-25 1985-02-28 Ici Australia Ltd D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions

Also Published As

Publication number Publication date
DE3442402A1 (de) 1985-05-30
DK548884A (da) 1985-05-22
HUT35955A (en) 1985-08-28
JPS60123419A (ja) 1985-07-02
IT1177262B (it) 1987-08-26
GB8429264D0 (en) 1984-12-27
CH662273A5 (fr) 1987-09-30
IT8423660A0 (it) 1984-11-20
NL8403528A (nl) 1985-06-17
DK548884D0 (da) 1984-11-19
HU196307B (en) 1988-11-28
GB8331037D0 (en) 1983-12-29
CA1236402A (en) 1988-05-10
IT8423660A1 (it) 1986-05-20
ZA849008B (en) 1985-07-31
GB2150024B (en) 1987-02-04
GB2150024A (en) 1985-06-26
AU3564984A (en) 1985-05-30
BE901095A (fr) 1985-05-20
FR2555047B1 (fr) 1987-04-17
ES537825A0 (es) 1985-10-16
FR2555047A1 (fr) 1985-05-24
NZ210247A (en) 1988-01-08

Similar Documents

Publication Publication Date Title
MX9202896A (es) Compuestos de 4''-ceto- y 4''-amino-4''-deoxi avermectina y sus derivados amino substituidos.
DK554084A (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
IT8324207A0 (it) Carbossamido-derivati di 1,2,4-tiadiazolo [3,2-a] pirimidine e procedimento per la loro preparazione
NZ185169A (en) 2,3-dihydroimidazo(2, 1-b) thiazole derivatives: process and pharmaceutical compositions
IT8448730A1 (it) Derivati di fredericamicina a aventi attivita' antibiotica ed antitumorale
AU1866576A (en) Tetrahydroimidazo(2,1-b)thiazole derivatives used as anthelmintics
ATE21248T1 (de) Derivate von 1h,3h-pyrrolo(1,2-c)thiazol, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK521585A (da) Fysisk stabilt anthelmintisk pastapraeparat
DE2961394D1 (en) 1-oxo-1h-pyrimido (6,1-b) benzothiazole derivatives, processes for their preparation and pharmaceutical compositions containing them
NZ211960A (en) Benz(5,6)isoindolo(2,1-b)isoquinoline-8,13-dione derivatives and pharmaceutical compositions
DE3061614D1 (en) 2,3-dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them
AU3564984A (en) Nitroxynil salt of levamisole used as anthelmintic
FI844153A7 (fi) 1,2-ditiolaanijohdannaiset, niiden valmistusmenetelmät, niitä sisältävät farmaseuttiset valmisteet ja niiden käyttö.
IT1157126B (it) N(vinblastin-23-il)derivati di aminoacidi loro preparazione ed applicazione terapeutica
KR890700762A (ko) 조성물로 제조된 로울로 몸체
DE3167565D1 (de) Anthelmintic imidazo(2,1-b)thiazole gel compositions
ES8602817A1 (es) Procedimiento para preparar composiciones anti-helminticas a base de derivados de tetramisol o levamisol.
AU563170B2 (en) Anthelmintic composition containing levamisole and benzimidazoles
IT8348061A0 (it) Tivita' antibiotica e procedimento derivati di carbapenem dotati di atper la loro preparzione
FI862164A0 (fi) Foerfarande foer framstaellning av pyridyl-substituerade imidazo/2,1-b/tiazoler.
MY100078A (en) Improvements relating to the expansion of tobacco.
FR2558163B1 (fr) Derives de phenyl-6 tetrahydro-2, 3, 5, 6 imidazo (2,1-b) thiazole
DE3472405D1 (en) Improvements in or relating to novel salts of dimeric indole-dihydroindole alkaloids
IT8419085A0 (it) Carbossi derivati di tiazolo[3,2-a]pirimidine sostituite e procedimento per la loro preparazione
IL53057A (en) 6-(m-(isothiazole-5-carboxamido)phenyl)-2,3,5,6-tetrahydroimidazo(2,1-b)thiazole derivatives,their preparation and anthelmintic compositions containing them